3

PRIMARY DOCUMENT

Company: PALVELLA THERAPEUTICS, INC.
Filed: August 1, 2019
Period of Report: July 31, 2019
Accession Number: 0001562180-19-004129

View Document ↗ View on SEC.gov ↗